Mabel , a Paris-based women’s health startup, has officially launched following two years of research and development and a €600K...

Treating alcohol use disorder (AUD) is one of the most challenging tasks in modern medicine, with high relapse rates and varied patient...

Psilocybin, the active compound in certain mushrooms, has gained significant attention for its potential to treat depression. Yet, its...

A Milestone for Psychedelic Research in Europe Earlier this year, in a landmark decision, the European Union has awarded €6.5 million to...

In the world of psychoactive mushrooms, the genus Psilocybe stands out for its storied history and widespread intrigue. Home to around...